Log in to save to my catalogue

Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy consid...

Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy consid...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2924538618

Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort

About this item

Full title

Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

The European journal of health economics, 2024-03, Vol.25 (2), p.269-279

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

End-stage kidney disease (ESKD) is associated with a substantial economic burden. In France, the cost of care for such patients represents 2.5% of the total French healthcare expenditures but serves less than 1% of the population. These patients’ healthcare expenditures are high because of the specialized and complex treatment needed as well as the...

Alternative Titles

Full title

Effect of comorbidities on healthcare expenditures for patients on kidney replacement therapy considering the treatment modality and duration in a French cohort

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2924538618

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2924538618

Other Identifiers

ISSN

1618-7598,1618-7601

E-ISSN

1618-7601

DOI

10.1007/s10198-023-01585-8

How to access this item